No subject area

OpenURL

Antihyperalgesic effects of spinal cannabinoids (with J. Richardson), European journal of pharmacology (1998)
 

OpenURL

R 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice (with J. Richardson and K. Hargreaves), European Journal of Pharmacology (1997)
 

OpenURL

Characterization of carrageenan-induced inflammation in the mouse (with J. Richardson), Society for Neuroscience (1996)
 

OpenURL

SR141716A, a cannabinoid receptor antagonist, induces NMDA-dependent hyperalgesia (with J. Richardson), Society for Neuroscience (1996)
 

OpenURL

Models for neuroscience education at undergraduate institutions (with C. Paul), Society for Neuroscience (1995)
 

OpenURL

Modulation of nociceptive thresholds by endogenous cannabinoids in normal animals (with J. Richardson and K. Hargreaves), Soc. Neuroscience Abstr (1995)
 

OpenURL

Binding-sites and Actions of Excitatory Amino-acids in Bovine Dental-pulp (with D. Jackson, J. Richardson, B. Wiski, N. Groves, and K. Hargreaves), Journal of Dental Research (1994)
 

OpenURL

Changes in spinal NK1 receptors accompany peripheral inflammation (with V.S. Seybold, C.L. Stucky, M.T. Galeazza, L.G. Abrahams, and A.M. Parsons), Neuropeptides, Nociception and Pain (1994)
 

OpenURL

ABA antinociception in the mouse spinal cord II: GABAA receptors and excitatory amino acids (with G. Wilcox), Journal of pharmacology and Experimental Therapeutics (1989)
 

OpenURL

Naloxone administration impairs autoshaped learning (with R. Messing, S. Allen, and S. Sparber), Behavioral and Neural Biology (1989)
 

OpenURL

High-performance liquid chromatographic analysis of diltiazem and its metabolite in plasma (with C. Verghese, M. Smith, E. Pritchett, and D. Shand), Journal of Chromatography B: Biomedical Sciences and Applications (1983)
 

OpenURL

Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen (with M. Reiter, D. Shand, R. Wagoner, and E. McCarthy), American Journal of Cardiology (1982)
 

OpenURL

Reduced verapamil clearance during long-term oral administration (with D. Shand, S. Hammill, and E. Pritchett), Clinical Pharmacology and Therapeutics (1981)